FAQ

Helt protein, mouse

Known as: Heslike protein, mouse, Hey-like transcription factor (zebrafish), mouse 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2014
0119982014

Related topics

Related topics

2 relations

Broader (2)

Basic Helix-Loop-Helix Transcription FactorsRepressor Proteins

Related mentions per year

Related mentions per year

1976-2018
197019801990200020102020
Helt protein, mouse
Basic Helix-Loop-Helix Transcription Factors
Repressor Proteins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Insulin-Like Growth Factor 2 Silencing Restores Taxol Sensitivity in Drug Resistant Ovarian Cancer
Drug resistance is an obstacle to the effective treatment of ovarian cancer. We and others have shown that the insulin-like… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer.
PURPOSE This study was undertaken to examine the role of the insulin-like growth factor (IGF) signaling pathway in the response… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2006
2006
Automation of analysis of cardiovascular autonomic function from chronic measurements of arterial pressure in conscious rats.
At present, there is no single software package that provides a comprehensive power spectral analysis of pulse interval (PI) and… (More)
Is this relevant?
2002
2002
Geschichte der Chirurgie des vorderen Kreuzbandes
Nachdem das vordere Kreuzband (VKB) bereits im Altertum erste schriftliche Erwähnung fand, erschienen erst im Verlauf des 19… (More)
Is this relevant?
1998
1998
Activity-Based Costing & Warm Fuzzies-- Costing , Presentation & Framing Influences on Decision-Making ~ A Business Optimization Simulation
(ABSTRACT) Activity-Based Costing is presented in accounting text books as a costing system that can be used to make valuable… (More)
  • table 2.1
  • figure 2.2
  • figure 2.3
  • figure 4.1
  • table 4.1
Is this relevant?